Form 4: Jeffrey Immelt Reports Stock Transaction in NeueHealth, Inc.
SEC Form 4 Filing
Director Jeffrey Immelt reports the vesting and disposal of 10,500 restricted stock units in NeueHealth, Inc. on May 13, 2025.
Summary
- Jeffrey Immelt, a director of NeueHealth, Inc., filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on May 13, 2025.
- Immelt disposed of 10,500 shares of common stock related to the vesting of restricted stock units.
- The transaction involved the vesting of restricted stock units, each representing a contingent right to receive one share of NeueHealth's common stock.
- Following the reported transaction, Immelt beneficially owns 23,919 shares of NeueHealth common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of transaction: Vesting and disposal of restricted stock units. |
| 05/15/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, NeueHealth, Immelt, Director, Stock, Restricted Stock Units, Beneficial Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.